Hold on to your shares: Apellis Pharmaceuticals Inc (APLS) Stock

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]

Investing in Apellis Pharmaceuticals Inc (APLS) Stock: Methodology

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]

There Is Nothing Like Apellis Pharmaceuticals Inc (APLS) Stock

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]

A positive surprise is on the way: Apellis Pharmaceuticals Inc (APLS) Stock

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]

The latest Apellis Pharmaceuticals Inc (APLS) Stock Technical Bulletin

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]

Why Apellis Pharmaceuticals Inc (NASDAQ:APLS) Stock rose 3.21% in Last Six Months?

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]

Apellis Pharmaceuticals Inc (APLS) Stock is the one stock you should own forever

Jefferies raised the price target for the Apellis Pharmaceuticals Inc (NASDAQ:APLS) stock from “a Hold” to “a Buy”. The rating was released on February 05, 2024, according to finviz. The research report from Goldman has initiated the stock to Buy, with a price target set at $74. The stock was initiated by Mizuho, who disclosed […]